Objective: Carboxy-terminal propeptide of type 1 procollagen (PICP) is a marker of extracellular collagen synthesis. Fragmented QRS (fQRS) on a 12-lead electrocardiogram (ECG) has been demonstrated as a marker of myocardial fibrosis. The present objective was to investigate the association between serum PICP concentration and presence of fQRS on ECG in hypertensive patients.
H ypertension is one of the most common diseases, globally, and is responsible for increased cardiovascular morbidity and mortality. [1] In hypertensive patients, left ventricular hypertrophy (LVH) is associated with increased risk of cardiovascular events. Myocyte hypertrophy and exaggerated accumulation of collagen occur in interstitial tissue, and lead to nonischemic myocardial fibrosis. [2] Research conducted in endomyocardial biopsy (EMB) and postmortem samples has demonstrated that the extent of myocardial collagen is increased in hypertensive patients, compared to normotensive individuals. [1, 2] Therefore, association between myocardial fibrosis and cardiovascular morbidity and mortality has been suggested. EMB is still the diagnostic gold standard for myocardial fibrosis, but is not routinely used, due to its invasive nature. [3] Carboxy-terminal propeptide of type 1 procollagen (PICP) is a marker of extracellular collagen synthesis. It has been reported that circulating PICP levels are higher in hypertensive patients than normotensive individuals, and that there is a significant correlation between serum PICP level and the amount of collagen content detected in EMB specimens. [4] Fragmented QRS (fQRS) on a 12-lead electrocardiogram (ECG) represents impaired ventricular conduction, and has been shown to be a marker of myocardial fibrosis or scar tissue in various clinical conditions. [4] [5] [6] [7] [8] Accordingly, prevalence of fQRS is relatively low among the healthy general population [9] and relatively high in patients with myocardial fibrosis or scarring. [5] [6] [7] [8] 10] The present study is the first to investigate the association of serum PICP concentration and presence of fQRS on ECG in hypertensive patients.
METHODS

Patients
Adult hypertensive patients who consecutively presented to the outpatient cardiology clinic were included. The following exclusion criteria were applied: (i) history of coronary artery disease, cardiomyopathy, rheumatic heart disease, diabetes mellitus, or systemic or metabolic disease. (ii) echocardiographic findings of reduced left ventricular ejection fraction (<55%), moderate to severe valve disease, wall motion abnormality, or ventricular dilatation, (iii) presence of liver or bone disease (which may effect serum PICP levels), (iv) use of drugs with anti-fibrotic properties, including angiotensin-convertingenzyme inhibitors, angiotensin-receptor blockers, and aldosterone antagonists, (v) presence of bundle branch block, atrial fibrillation, or paced rhythm. All included patients were in sinus rhythm.
Body mass index (BMI) was calculated as weight in kilograms divided by square of height in meters. Obesity was defined as a BMI of 30 kg/m 2 or higher. Estimated glomerular filtration rate (eGFR) was calculated using the Modification of Diet in Renal Disease equation: eGFR (mL/min/1.73 m 2 ) = 186 x creatinine-1.154 * age-0.203 * 0.742 (if female) * 1.212 (if the patient was black)
Diagnosis of hypertension
Blood pressure (BP) measurements taken at home and the hospital, or data obtained from ambulatory BP monitoring, were used to diagnose hypertension.
Blood pressure measured in the hospital
After ≥10 min of rest, systolic BP and diastolic BP were obtained from the right arms of patients seated and supported at the level of the heart, using a sphygmomanometer (Erka Kallmeyer Medizintechnik GmbH & Co. KG, Bad Tölz, Germany). Patients with BP ≥140/90 mmHg were considered hypertensive. Caffeine intake and tobacco use were restricted for 30 minutes prior to obtaining BP. At least 2 BP readings were recorded during the study period.
Blood pressure measured at home
Patients with BP ≥135/85 mmHg over 3 consecutive days were considered hypertensive. time BP of ≥135/85 mmHg, and average nighttime BP of ≥120/70 mmHg were considered hypertensive.
Ambulatory blood pressure monitoring
Echocardiographic examination
Transthoracic echocardiographic examinations were performed with the subject in the left side supine position, using a Vivid 3 ultrasound machine with a 3.2-MHz transducer (GE Vingmed Ultrasound AS, Horten, Norway). Conventional M-mode and B-mode parameters were measured in accordance with the American Society of Echocardiography guidelines. [11] Left ventricular end-diastolic (LVEDD) and endsystolic diameters, and posterior (PWT) and septal (IVST) wall thicknesses were measured. Left ventricular mass (LVM) was calculated using the Devereux equation: LVM = 0.8(1.04[LVEDD + IVST +PWT] 3 -LVEDD 3) + 0.6. [12] Left ventricular mass index (LVMI) was calculated by dividing LVM by body surface area. LVH was defined as LVMI >115 g/m 2 for men and 95 g/m 2 for women.
[13]
Assessment of fQRS
Resting 12-lead ECG recordings (filter range: 0.15-100 Hz; AC filter: 60 Hz; 25 mm/s; 10 mm/mV) were assessed by 2 independent cardiologists blinded to clinical findings of patients. fQRS ( Figure 1 ) was defined as presence of additional R', or notching of R' or S-wave, or the presence of fragmentation (more than 1 R') in 2 contiguous ECG leads.
[14]
Assessment of PICP levels
Fasting blood samples collected for routine analyses were portioned and stored at -40°C. Serum PICP levels were measured by enzyme-linked immunosorbent assay method using commercially available kits (Cusabio Biotech Co., Ltd., College Park, MD, USA). Lower detection limit of kits was 0.32 ng/mL. Approval was obtained from the institutional ethics committee (project no: 13-KAEK-058). Figure 2 . Patients with or without fQRS were similar, with respect to other baseline characteristics, as shown in Table 1 . Receiver operating characteristic curve analysis ( Figure 3 ) yielded a strong predictive ability of PICP levels for Table 2 ). The association was still evident, even after adjustment for LVMI.
Statistical analysis
DISCUSSION
It is well-known that LVH is a more important risk factor for hypertensive patients than age, serum cholesterol level, BP level, or presence of coronary artery disease. LVH is associated with increased cardiovascular morbidity and mortality, [15] and is a strong, independent risk factor for cardiac failure, coronary artery disease, arrhythmia, and stroke. [8] Myocyte hypertrophy and excessive accumulation of collagen occur in LVH, leading to disproportionate increase of fibrous tissue in the myocardium. [2] LVH may also occur in athletic heart syndrome without myocardial fibrosis, due to proportional increase of LVM. [16] Myocardial fibrosis is a crucial factor for LVH in hypertensive patients, and is associated with adverse cardiac events. Therefore, detection of collagen accumulation can aid in the prediction of clinical course and treatment planning. [17] EMB is still the diagnostic gold standard for the diagnosis of myocardial fibrosis, but is not routinely used due to its invasive nature. Myocardial fibrosis can be detected by cardiac magnetic resonance imaging and scintigraphic methods, in addition to histopathological evaluation. [18] Serum PICP is a biochemical marker of extracellular collagen type 1 synthesis, and has higher sensitivity and specificity in the determination of myocardial fibrosis. A significant correlation has been shown between serum PICP levels and the amount of collagen detected in histopathological examination of tissue biopsies. [2, 19] fQRS is easily detected on a routine 12-lead ECG, and indicates altered ventricular conduction, which is related to myocardial fibrosis. [14, 20] A strong association between fQRS detected on ECG and myocardial fibrosis, as assessed by gadolinium-enhanced cardiac magnetic resonance imaging, has been demonstrated in several studies. [5, 7, 8] However, the potential association of fQRS with myocardial fibrosis in hypertensive patients had yet to be investigated. In the present study, hypertensive patients with fQRS had significantly higher left ventricular wall thickness, LVM, LVMI, prevalence of LVH, and serum PICP levels, compared to hypertensive patients without fQRS. Moreover, there was a strong and independent association between serum PICP levels and presence of fQRS on ECG. The present results suggested that fQRS on ECG indicated underlying myocardial fibrosis in patients with hypertension.
Myocardial fibrosis may prolong myocardial conduction time, which may disrupt QRS morphology and lead to development of fQRS. Hypertensive patients have abnormal left ventricular geometry and higher incidence of LVH. [21, 22] It has also been suggested that hypertensive patients with fQRS have higher incidence of complex ventricular arrhythmias. This may be the result of ectopic impulses and re-entry circuits, caused by myocardial fibrosis. [18] Similarly, the presence of fQRS has been linked to higher risk of atrial arrhythmia. [23, 24] Procollagens are produced by fibroblasts and secreted to the extracellular space. Carboxy terminal propeptide terminals of procollagens are removed by specific endopeptidases during collagen synthesis, released into the blood, and cleared by the liver. [2] Serum PICP is a marker of myocardial fibrosis, and has better correlation with myocardial collagen content. [2] It was presently found that serum PICP levels were increased in hypertensive patients with fQRS. This increase may be related to increased synthesis of myocardial collagen and myocardial fibrosis, leading to prolonged ventricular conduction time in hypertensive patients with fQRS. Myocardial fibrosis is a well-known predisposing factor for left ventricular dysfunction, arrhythmia, and sudden cardiac death, and is related to increased cardiovascular risk. [25, 26] Early diagnosis of myocardial fibrosis can be effective for both risk classification and selection of drugs used in the treatment of cardiovascular disease.
Limitations
Several limitations may have affected the present results, primarily small sample size. Myocardial fibrosis was not investigated with advanced imaging modalities or histopathological examination. Although patients on angiotensin-converting-enzyme inhibitors, angiotensin-receptor blockers, or aldosterone antagonists were excluded, the possible effects of other antihypertensive medications on myocardial fibrosis could not entirely be accounted for.
Conclusions
Serum PICP level is a strong and independent predictor of fQRS; discriminative performance of serum PICP level for the presence of fQRS on ECG was high. The first evidence that fQRS may indicate myocardial fibrosis in hypertensive patients was provided in the present study. Our data suggests that fQRS may be a useful tool in the assessment of myocardial fibrosis in patients with hypertension. fQRS is a simple, inexpensive, and widely available tool, which may have additional benefits in the risk assessment of patients with hypertension.
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